Open Access<p>12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women</p>
Author(s) -
Meng Kong,
Kai Zhu,
Yiran Zhang,
Mengxiong Song,
Hao Zhang,
Qihao Tu,
Xuexiao Ma
Publication year - 2019
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s224663
Subject(s) - medicine , teriparatide , quality of life (healthcare) , visual analogue scale , percutaneous vertebroplasty , back pain , osteoporosis , incidence (geometry) , logistic regression , bone mineral , percutaneous , adverse effect , surgery , physics , alternative medicine , nursing , pathology , optics
Define the effectiveness of teriparatide (TPTD) treatment on reducing the incidence of new vertebral compression fractures (NVCFs) and back pain and improving quality of life after percutaneous kyphoplasty (PKP).